Earnings releaseFrench
Résultats annuels 2025 : Forte croissance des ventes, enrichissement du portefeuille clients et de BioSolutions, renforcement de la structure financière grâce à Huvepharma
The file is served by the AMF. We do not host a copy.
Next publication
Half-year financial report · H1
announced in this filingDocument type
- Issuer
- Fermentalg
- Filed
- 02/04/2026, 18:00
- Document type
- Earnings release
- AMF sub-type
- Informations privilégiées
- Language
- French
- AMF reference
- 078982_20260402